Literature DB >> 22016262

Demographic characteristics of SMA type 1 patients at a tertiary center in Turkey.

Barış Ekici1, Betül Bozkurt, Burak Tatlı, Mine Calışkan, Nur Aydınlı, Meral Ozmen.   

Abstract

UNLABELLED: The aim of this study was to demonstrate demographics of 39 consecutive Spinal Muscular Atrophy (SMA) type 1 patients diagnosed genetically in a tertiary center between June 2006 and June 2009. There was history of consanguineous marriage in 27 (69%) patients. The average patient lifespan was 251 days (30-726 days). The average patient age at diagnosis was 129 days (33-297 days). A statistically significant correlation was found between the age at diagnosis and the lifespan (p = 0.00). No significant correlation was found between the time spent in intensive care and the lifespan (p = 0.43). Routine physical therapy was found to have no significant impact on the lifespan average (p = 0.17). The cause of death in all of our patients was respiratory issues. Genetic counseling was given to 35 families. A second child with SMA was born in three out of the 14 families who declined prenatal diagnosis.
CONCLUSION: A national program is needed in Turkey for SMA prevention and creation of expert teams for the management of these patients.

Entities:  

Mesh:

Year:  2011        PMID: 22016262     DOI: 10.1007/s00431-011-1607-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

Review 1.  The genetics of spinal muscular atrophies.

Authors:  Claribel D Wee; Lingling Kong; Charlotte J Sumner
Journal:  Curr Opin Neurol       Date:  2010-10       Impact factor: 5.710

Review 2.  Respiratory management of the infant with type 1 spinal muscular atrophy.

Authors:  A Bush; J Fraser; E Jardine; J Paton; A Simonds; C Wallis
Journal:  Arch Dis Child       Date:  2005-07       Impact factor: 3.791

3.  Hemoglobinopathy control program in Turkey.

Authors:  Duran Canatan; M Rifat Kose; Munip Ustundag; Dilek Haznedaroglu; Sema Ozbas
Journal:  Community Genet       Date:  2006

Review 4.  Spinal muscular atrophy diagnostics.

Authors:  Thomas W Prior
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

5.  The changing natural history of spinal muscular atrophy type 1.

Authors:  M Oskoui; G Levy; C J Garland; J M Gray; J O'Hagen; D C De Vivo; P Kaufmann
Journal:  Neurology       Date:  2007-11-13       Impact factor: 9.910

Review 6.  Early infantile form of spinal muscular atrophy (Werdnig-Hoffmann disease) with prolonged survival.

Authors:  Janina Borkowska; Sabine Rudnik-Schoneborn; Irena Hausmanowa-Petrusewicz; Klaus Zerres
Journal:  Folia Neuropathol       Date:  2002       Impact factor: 2.038

7.  Survival in SMA type I: a prospective analysis of 34 consecutive cases.

Authors:  J M Cobben; H H Lemmink; I Snoeck; P A Barth; J H van der Lee; M de Visser
Journal:  Neuromuscul Disord       Date:  2008-06-24       Impact factor: 4.296

8.  Respiratory capacity course in patients with infantile spinal muscular atrophy.

Authors:  Christine Ioos; Danièle Leclair-Richard; Slah Mrad; Annie Barois; Brigitte Estournet-Mathiaud
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

9.  Survival probabilities of patients with childhood spinal muscle atrophy.

Authors:  Mohannad M Mannaa; Maninder Kalra; Brenda Wong; Aliza P Cohen; Raouf S Amin
Journal:  J Clin Neuromuscul Dis       Date:  2009-03

10.  Survival analysis of spinal muscular atrophy type I.

Authors:  Hyun Bin Park; Soon Min Lee; Jin Sung Lee; Min Soo Park; Kook In Park; Ran Namgung; Chul Lee
Journal:  Korean J Pediatr       Date:  2010-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.